Venus Remedies bags Market Authorization of Meropenem Injection from, TGA, Australia
Venus Remedies Ltd has informed BSE regarding "Venus Remedies bags Market Authorization of Meropenem Injection from, TGA, Australia"20-05-2014
20-05-2014
Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Venus Remedies Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 199219-05-2014
Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Venus Remedies Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 199213-05-2014
Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Venus Remedies Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 199208-05-2014
Shareholding Pattern for March 31, 2014
Venus Remedies Ltd has informed BSE about the Shareholding Pattern for the Quarter ended March 31, 2014.15-04-2014
Venus gets marketing nod from Venezuela for meropenem
Venus Remedies Ltd has informed BSE regarding "Venus gets marketing nod from Venezuela for meropenem".03-04-2014
Venus bags marketing approval from Myanmar for its flagship product Elores
Venus Remedies Ltd has informed BSE regarding "Venus bags marketing approval from Myanmar for its flagship product Elores".26-02-2014
Financial Results & Limited Review for Dec 31, 2013
Venus Remedies Ltd has informed BSE about the Financial Results & a copy of the Limited Review Report for the period ended December 31, 2013.12-02-2014
Venus receives Indonesian GMP for its Baddi unit
Venus Remedies Ltd has informed BSE regarding "Venus receives Indonesian GMP for its Baddi unit"05-02-2014
Venus Remedies bags US patent for Achnil
Venus Remedies Ltd has informed BSE regarding "Venus Remedies bags US patent for Achnil".29-01-2014